Amgen Bags Onyx For $10.4B After Quick Chase
Onyx Pharmaceuticals Inc. bowed this weekend to suitor Amgen Inc., agreeing to be acquired for $125 per share, or $10.4 billion, six weeks after rejecting a lower offer and seeking other...To view the full article, register now.
Already a subscriber? Click here to view full article